HCA Healthcare's Q1 earnings dip amid mild flu season and harsh weather
HCA Healthcare has reported a weaker-than-expected first quarter, citing a mild respiratory season and harsh winter weather as key factors. The company faced a $180 million hit to adjusted earnings, though executives remain optimistic about the rest of the year.
Respiratory-related admissions plunged by 42% compared to last year, while emergency room visits for respiratory illnesses dropped by 32%. The mild flu season and severe weather conditions contributed to these declines, reducing patient volumes.
Exchange-based admissions also fell by 15%, while uninsured patient numbers rose by 16%. This shift in payer mix, combined with exchange-related changes, is expected to create a $600 million to $900 million headwind to full-year EBITDA. Despite these challenges, HCA saw a 3.1% increase in revenue per equivalent admission, indicating that higher pricing and patient acuity helped offset some of the volume declines. A late-quarter rebound in patient numbers and stronger-than-expected Medicaid supplemental payments—totalling $200 million—provided some relief. CEO Sam Hazen described the pressures as 'first quarter events' and expressed confidence in the company’s outlook for the remainder of 2024. Executives also highlighted the importance of CFOs focusing on supplemental payment opportunities, improving revenue cycle performance, and converting uninsured patients to active coverage.
The quarter’s performance underscores the need for healthcare providers to build resilience against volume fluctuations and reassess risks tied to payer mix shifts. HCA’s late rebound and supplemental payments suggest some stability, but full-year earnings will still face significant headwinds from exchange-related changes.
